Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5 Suppl B
|
pubmed:dateCreated |
1987-12-4
|
pubmed:abstractText |
The coronary lesion in unstable angina consists of disrupted atherosclerotic plaque with nonocclusive intraluminal thrombus, which frequently persists despite heparin anticoagulation. A 12 hour infusion of recombinant tissue-type plasminogen activator combined with heparin effectively lyses the thrombus and stabilizes the clinical syndrome but is associated with a high incidence of bleeding. Therapeutic schemes of thrombolytic therapy associated with a lower bleeding frequency may be useful for the treatment of unstable angina.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0735-1097
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
91B-95B
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3117861-Angina, Unstable,
pubmed-meshheading:3117861-Angina Pectoris,
pubmed-meshheading:3117861-Clinical Trials as Topic,
pubmed-meshheading:3117861-Coronary Angiography,
pubmed-meshheading:3117861-Coronary Thrombosis,
pubmed-meshheading:3117861-Coronary Vessels,
pubmed-meshheading:3117861-Fibrinolytic Agents,
pubmed-meshheading:3117861-Heparin,
pubmed-meshheading:3117861-Humans,
pubmed-meshheading:3117861-Myocardial Infarction,
pubmed-meshheading:3117861-Random Allocation,
pubmed-meshheading:3117861-Recombinant Proteins,
pubmed-meshheading:3117861-Tissue Plasminogen Activator
|
pubmed:year |
1987
|
pubmed:articleTitle |
Thrombolytic therapy for unstable angina pectoris: rationale and results.
|
pubmed:affiliation |
Cardiac Division, Massachusetts General Hospital, Boston 02114.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Review
|